Filing Details

Accession Number:
0001250853-14-000054
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-02-13 20:22:19
Reporting Period:
2014-02-07
Filing Date:
2014-02-13
Accepted Time:
2014-02-13 20:22:19
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1390478 Galena Biopharma Inc. GALE Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1297775 Rudolph Nisi 4640 S.w. Macadam Avenue, Suite 270
Portland OR 97239
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-02-07 20,000 $4.94 23,500 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The reporting person's purchase of GALE common stock reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934 with the reporting person's sale of 20,000 shares of GALE common stock at an average price of $7.111514 per share on January 17, 2014. The reporting person has agreed to pay to GALE $43,487.78, representing the full amount of the profit realized in connection with the short-swing transaction.
  2. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.9151 to $4.95, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote to this Form 4.